Skip to content

Types of Intimate Partner Violence and Women's Health

Types of Intimate Partner Violence and Women's Health: Findings From the WHO Multi-country Study on Women's Health and Intimate Partner Violence

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03469739
Enrollment
29990
Registered
2018-03-19
Start date
2016-06-30
Completion date
2017-08-31
Last updated
2018-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Domestic Violence

Keywords

Intimate Partner Violence

Brief summary

This study uses data from 29,990 women from 12 different countries collected by the WHO multi-country study on women's health and domestic violence to capture the effect of different types, frequency and timing of IPV on self-reported health, symptoms and suicidal behaviours.

Detailed description

Intimate partner violence (IPV) has detrimental effects on physical and mental health, risks to children and is associated with wider societal and healthcare costs. Previous analysis of the WHO multi-country study on women's health and domestic violence found significant associations between physical and sexual IPV and self-reported ill-health, symptomatology and suicidal behaviours. Real experience of IPV can comprise different combinations of emotional, physical and sexual abuse, and different timings and frequencies of these. A more nuanced testing of exposure to these different combinations of IPV and associations with health is needed. This study uses data from 29,990 women from 12 different countries collected by the WHO multi-country study on women's health and domestic violence to capture the effect of different combination types, frequency and timing of IPV on self-reported health, symptoms and suicidal behaviours.

Interventions

None listed

Sponsors

University of Bristol
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
15 Years to 49 Years
Healthy volunteers
Yes

Inclusion criteria

* The WHO report that in most sites, a representative sample of women was obtained using a two-stage cluster sampling scheme to select households and then only one woman per household was randomly selected per household for interview.

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Participant description of their current overall state of healthPreceding 4 weeksParticipant description of their current overall state of health- a choice of options- excellent, good, fair, poor or very poor.

Secondary

MeasureTime frameDescription
Participant reported health in the last 4 weeks- problems walking around, doing usual activities, pain or discomfort, problems with memory or concentration, dizziness or vaginal discharge. Measured by questionnaire.Preceding 4 weeksParticipant rating of various health aspects in last 4 weeks
Emotional distress. Measured by questionnaire of 20 different symptoms of emotional distress. SRQ-20 (score of 20 different symptoms of emotional distress with yes/no answers)Preceding 4 weeksSelf Reporting Questionnaire-20 (SRQ-20)- aggregate score of 20 different symptoms of emotional distress with yes/no answers
Participant reported ever suicidal thoughts or attempts; measured by questionnaire.Up to 49 yearsParticipants reporting ever having suicidal thoughts or ever attempting suicide
Participant reported medication used for sleep/ pain; measured by questionnaire.Preceding 4 weeksParticipants reporting medication use

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026